ELAN News and Press, Elanco Animal Health Incorporated From 07/19/21

Elanco Animal Health (NYSE: ELAN) just announced another acquisition after its deal to acquire Bayer Animal Health last year . This time, the animal health company is purchasing Kindred Biosciences (NASDAQ: KIN) for $440 million. Kindred focuses on dermatology treatments...

Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2021 financial results on Monday, August 9, 2021. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The co...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Jeff Smith’s 13F portfolio value increased from ~$3.93B to ~$4.69B this quarter. Starboard Value added Elanco Animal Health and eHealth, while dropping Advanced Auto Parts this quarter. The largest three individual stock positions are Corteva, Aecom, and NortonLifeLock. The...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

gerenme/iStock via Getty Images The advancements in treatments for Alzheimer’s disease have spurred gains among large-cap pharmaceutical companies in the first half of 2021. Eisai ([[ESALY]] -0.9%) and Eli Lilly ([[LLY]] +0.7%) are among the five leading gainers in the pharmaceutical s...

First external organization to contribute to RestaurAmazônia Project combining cocoa cultivation with cattle raising in the Amazon Today, the Elanco Foundation announces a partnership with the JBS Fund for the Amazon (The Fund) to jointly support the RestaurAmaz &...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips InvestorPlace’s Mark Hake estimates Zomedica (NYSEAMERICAN: ZOM ) is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy at current prices.  Source: Postmodern Studio / Shutterstoc...

CAI International and Mitsubishi HC Capital join forces. At Home Group receives an improved offer but its largest shareholder is not happy with the higher offer. Multiple active deals receive required regulatory and shareholder approvals. For further details see: Merger ...

The remote lifestyle forced by the COVID-19 pandemic boosted pet ownership over the past year. As a result, the pet industry has been faced with huge demand for pet food and medications. In response to this, pet companies are racing to develop quality food products and viable drugs and diagno...